Knowledge Base • NCK Pharma

31 Jul 2021

Takeda and Frazier announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize Takeda’s norovirus vaccine candidate

Posted Byadmin

Comments0

TagsFrazier Healthcare, HilleVax, norovirus, norovirus vaccine, Takeda

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop...

31 Jul 2021

Nucala received USFDA approval to treat chronic rhinosinusitis with nasal polyps

Posted Byadmin

Comments0

TagsGSK, nucala

GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) have approved Nucala (mepolizumab), a monoclonal antibody that targets...

19 Jul 2021

Case Insight: Piramal Pharma’s acquisition of Hemmo Pharmaceuticals

Posted Byadmin

Comments0

Tagsacquisition in pharma, Piramal

Piramal Pharma Ltd has completed the acquisition of Hemmo Pharmaceuticals. In March this year, Piramal Pharma Ltd entered into an...

19 Jul 2021

FDC launches Favipiravir oral suspension to treat mild to moderate cases of COVID-19

Posted Byadmin

Comments0

TagsCOVID-19, FDC

Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases...

19 Jul 2021

Rossari Biotech to acquire Tristar Intermediates

Posted Byadmin

Comments0

TagsRossari Biotech, Tristar Intermediates

Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of...

16 Jul 2021

Sun Pharma launches a special initiative ‘Sunkalp’ for the welfare of doctors

Posted Byadmin

Comments0

Sun Pharmaceutical Industries launched a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. The company...

16 Jul 2021

Kintor Pharmaceutical collaborates with Fosun Pharma Development to Commercialise Proxalutamide

Posted Byadmin

Comments0

TagsFosun Pharma, Kintor Pharmaceutical, proxalutamide

Kintor Pharmaceutical Limited today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. (“Fosun...

14 Jun 2021

Lupin’s Somerset plant received US FDA warning letter for

Posted Byadmin

Comments0

Tagsofficial action indicated, USFDA warning letter

Lupin has received a warning letter from the US Food and Drug Administration relating to its US-based manufacturing plant located...

12 Jun 2021

What is Cytokine Storm?

Posted Byadmin

Comments0

Tagscytokine storm

Cytokine Storm is a severe immune reaction in which the body releases too many cytokines into the blood too quickly....

10 Jun 2021

FDA Grants Accelerated Approval for Alzheimer’s drug Aduhelm

Posted Byadmin

Comments0

Tagsaducanumab, Aduhelm, Biogen, Eisai, global pharma licensing deal, monoclonal antibody, Neurimmune, pharma deal

USFDA approved Aduhelm (aducanumab) for the treatment of Alzheimer disease. Alzheimer’s drug Aduhelm is research molecule of Neurimmune. Neurimmune licensed...

10 Jun 2021

Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan

Posted Byadmin

Comments0

TagsDaewoong, fexuprazan, Neurogastrx

Neurogastrx, Inc. has entered into an exclusive license agreement with Daewoong Pharmaceutical Co., Ltd., of Seoul, South Korea, for the...

4 Jun 2021

Case study – Adagrasib out licensing deal

Posted Byadmin

Comments0

Zai Lab said on Tuesday it has entered into a license agreement with Mirati Therapeutics to develop and commercialize Mirati’s KRAS...

4 Jun 2021

CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China

Posted Byadmin

Comments0

Tagschina FDA, Medical device approval, medical device company

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has...

4 Jun 2021

Cosentyx of Novartis Gets US FDA approval in Pediatric Plaque Psoriasis

Posted Byadmin

Comments0

Tagscornerstone cytokine, cosentyx, Cosentyx for plaque psoriasis, novartis, Novartis got approval for Cosentyx, Plaque psoriasis, psoriasis

The U.S. Food and Drug Administration (FDA) has approved Novartis’ blockbuster drug Cosentyx® (secukinumab) for pediatric patients aged six years and older with moderate-to-severe...

3 Jun 2021

Corbus Pharma in-licenses two integrin targeting MAbs

Posted Byadmin

Comments0

Tagsanti-integrin MAbs, MAB

US biotech Corbus Pharmaceuticals (Nasdaq: CRBP) today announced the expansion of its portfolio into immuno-oncology through licensing deals for two...

3 Jun 2021

Case Study: Strategic Insight of acquisition of Constellation Pharmaceuticals by MorphoSys

Posted Byadmin

Comments0

TagsConstellation Pharmaceuticals, MorphoSys AG, pharma deal, pharma strategic deal, strategic management in pharma

MorphoSys AG, and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation...

3 Jun 2021

Amryt’s filed Oleogel-S10 NDA for the treatment of Epidermolysis Bullosa

Posted Byadmin

Comments0

TagsAmryt, Oleogel-S10

Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that...

3 Jun 2021

Insight on Sun Pharma’s Licensing Agreement with Ferring Pharmaceutical for Caritec in India

Posted Byadmin

Comments0

TagsCarbetocin, Caritec, Ferring Pharma, Sun Pharma

Sun Pharmaceutical Industries entered into a licensing agreement with Ferring Pharmaceuticals to commercialise innovative obstetric drug Caritec in India. One...

28 May 2021

EMA authorises Pfizer covid vaccine “Comirnaty” for 12-15 yrs

Posted Byadmin

Comments0

TagsComirnaty, Covid vaccine, pfizer

EMA has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12...

28 May 2021

Insight on US FDA approval of Myfembree OD treatment for management of heavy menstrual bleeding associated with uterine fibroids

Posted Byadmin

Comments0

TagsMyfembree, Myovant Sciences, pfizer

Myovant Sciences and Pfizer announced that the US Food and Drug Administration (FDA) has approved Myfembree (relugolix 40 mg, estradiol...

28 May 2021

Carlyle Group to acquire british pharma firm Vectura for $1.4bn

Posted Byadmin

Comments0

Private equity firm Carlyle Group on Wednesday announced plans to buy U.K. drug contractor Vectura in a deal that values...

11 May 2021

DCGI – India approved anti-Covid drug 2-DG developed by DRDO for emergency use

Posted Byadmin

Comments0

Tags2-DG, Dr. Reddy’s Laboratories, DRDO, DRL

The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied...

11 May 2021

Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India

Posted Byadmin

Comments0

TagsBaricitinib, Cipla, Eli Lilly, Lupin, Sun Pharma

US drug-maker Eli Lilly, on May 10, announced that it had issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical...

28 Apr 2021

Case Study: Pfizer acquires Amplyx Pharmaceuticals

Posted Byadmin

Comments0

Tagsacquisition, acquisition in pharma, Fosmanogepix, pfizer, Pfizer's Acquisition of Anacor, pharma deal, Why Pfizer to acquire AM Pharma

Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s...

11 Feb 2021

Philips acquired US-based remote medical technology company, BioTelemetry

Posted Byadmin

Comments0

Royal Philips, a global leader in health technology, announced that it has completed the acquisition of BioTelemetry, Inc., a leading...

11 Feb 2021

Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma

Posted Byadmin

Comments0

Tagsotenaproxesul

Antibe Therapeutics Inc. licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company...

11 Feb 2021

Insight on why Jazz Pharmaceuticals to acquire GW Pharma?

Posted Byadmin

Comments0

TagsEpidiolex, GW Pharma, Jazz Pharmaceuticals

GW Pharmaceuticals announced they have entered into an agreement with Jazz Pharmaceutical. As per the agreement, Jazz to acquire GW...

10 Feb 2021

ViiV Healthcare’s Rukobia received EMA marketing authorisation

Posted Byadmin

Comments0

Tagsfostemsavir, HIV-1 attachment inhibitor, Rukobia, ViiV Healthcare

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc and Shionogi Limited as...

10 Feb 2021

Sanofi received additional indication approval for Plavix

Posted Byadmin

Comments0

Tagsadditional indication approval, plavix, Sanofi

European Commission (EC) has approved an additional indication for Plavix (clopidogrel) to include its use in combination with aspirin in...

10 Feb 2021

CoronaVac received conditional marketing authorization from NMPA China

Posted Byadmin

Comments0

Sinovac Biotech announced that the China National Medical Products Administration (NMPA) has granted a conditional marketing authorization (CMA) to Sinovac...

Recently Published Articles

Takeda and Frazier announced a collaboration to launch HilleVax, Inc, a biopharmaceutical company, to develop and commercialize Takeda’s norovirus vaccine candidate

Nucala received USFDA approval to treat chronic rhinosinusitis with nasal polyps

Case Insight: Piramal Pharma’s acquisition of Hemmo Pharmaceuticals

FDC launches Favipiravir oral suspension to treat mild to moderate cases of COVID-19

Rossari Biotech to acquire Tristar Intermediates

Sun Pharma launches a special initiative ‘Sunkalp’ for the welfare of doctors

Kintor Pharmaceutical collaborates with Fosun Pharma Development to Commercialise Proxalutamide

Lupin’s Somerset plant received US FDA warning letter for

What is Cytokine Storm?

FDA Grants Accelerated Approval for Alzheimer’s drug Aduhelm

Insight on Neurogastrx licensing deal with Daewoong Pharmaceutical to Develop Fexuprazan

Case study – Adagrasib out licensing deal

CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China

Cosentyx of Novartis Gets US FDA approval in Pediatric Plaque Psoriasis

Corbus Pharma in-licenses two integrin targeting MAbs

Case Study: Strategic Insight of acquisition of Constellation Pharmaceuticals by MorphoSys

Amryt’s filed Oleogel-S10 NDA for the treatment of Epidermolysis Bullosa

Insight on Sun Pharma’s Licensing Agreement with Ferring Pharmaceutical for Caritec in India

EMA authorises Pfizer covid vaccine “Comirnaty” for 12-15 yrs

Insight on US FDA approval of Myfembree OD treatment for management of heavy menstrual bleeding associated with uterine fibroids

Carlyle Group to acquire british pharma firm Vectura for $1.4bn

DCGI – India approved anti-Covid drug 2-DG developed by DRDO for emergency use

Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India

Case Study: Pfizer acquires Amplyx Pharmaceuticals

Philips acquired US-based remote medical technology company, BioTelemetry

Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma

Insight on why Jazz Pharmaceuticals to acquire GW Pharma?

ViiV Healthcare’s Rukobia received EMA marketing authorisation

Sanofi received additional indication approval for Plavix

CoronaVac received conditional marketing authorization from NMPA China

Your form has been submitted